Astec Lifesciences Board of Directors

Get the latest insights into the leadership at Astec Lifesciences. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Nadir B Godrej Chairman
Mr. Burjis N Godrej Managing Director
Mr. Balram Singh Yadav Non Executive Director
Mr. Ashok V Hiremath Non Executive Director
Dr. Ganapati Yadav Independent Director
Mr. R R Govindan Independent Director
Mr. Nandkumar Dhekne Independent Director
Ms. Anjali Gupte Independent Director

Astec Lifesciences Share price

ASTEC

853.1

0.35 (-0.04%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:31 IST
BUYSELL
Today's High

867.60

Today's Low

850.15

52 Week Low

628.32

52 Week High

1320.30

The current prices are delayed, login to your account for live prices

Astec Lifesciences FAQs

The board at Astec Lifesciences consists of experienced professionals, including Mr. Nadir B Godrej , Mr. Burjis N Godrej , and others, overseeing the company’s strategic and corporate governance.

Directors at Astec Lifesciences are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Nadir B Godrej is the current chairman at Astec Lifesciences.

Executive directors at Astec Lifesciences are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Astec Lifesciences adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Astec Lifesciences, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.